Altimmune, Inc. (ALT)
NASDAQ: ALT · Real-Time Price · USD
2.740
-0.060 (-2.14%)
At close: Apr 28, 2026, 4:00 PM EDT
2.780
+0.040 (1.46%)
After-hours: Apr 28, 2026, 7:55 PM EDT
Altimmune Employees
Altimmune had 57 employees as of December 31, 2025. The number of employees decreased by 2 or -3.39% compared to the previous year.
Employees
57
Change (1Y)
-2
Growth (1Y)
-3.39%
Revenue / Employee
$719
Profits / Employee
-$1,545,491
Market Cap
532.11M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Lyell Immunopharma | 300 |
| ProKidney | 231 |
| Rigel Pharmaceuticals | 174 |
| Sutro Biopharma | 137 |
| Kyverna Therapeutics | 130 |
| Ocugen | 116 |
| Adlai Nortye | 109 |
| Tectonic Therapeutic | 60 |
ALT News
- 1 day ago - Altimmune Announces Closing of $225 Million Oversubscribed Public Offering of Securities - GlobeNewsWire
- 5 days ago - Altimmune Announces Pricing of $225 Million Oversubscribed Public Offering of Securities - GlobeNewsWire
- 6 days ago - Altimmune Announces Proposed Underwritten Public Offering of Securities - GlobeNewsWire
- 12 days ago - Altimmune Transcript: AGM 2026 - Transcripts
- 6 weeks ago - Altimmune Transcript: Barclays 28th Annual Global Healthcare Conference - Transcripts
- 6 weeks ago - Altimmune Transcript: Leerink Global Healthcare Conference 2026 - Transcripts
- 7 weeks ago - Altimmune Transcript: The Citizens Life Sciences Conference 2026 - Transcripts
- 7 weeks ago - Altimmune Earnings Call Transcript: Q4 2025 - Transcripts